These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22452971)

  • 1. Newer fecal tests: opportunities for professionals in laboratory medicine.
    Fraser CG; Allison JE; Young GP; Halloran SP
    Clin Chem; 2012 Jun; 58(6):963-5. PubMed ID: 22452971
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study.
    Kok L; Elias SG; Witteman BJ; Goedhard JG; Muris JW; Moons KG; de Wit NJ
    Clin Chem; 2012 Jun; 58(6):989-98. PubMed ID: 22407858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fecal calprotectin in complex diagnostics of intestinal diseases].
    Livzan MA; Dolgikh TI; Lialiukova EA
    Eksp Klin Gastroenterol; 2013; (12):83-6. PubMed ID: 24933995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fecal calprotectin].
    Rodrigo L
    Rev Esp Enferm Dig; 2007 Dec; 99(12):683-8. PubMed ID: 18290690
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive Value of Fecal Calprotectin in Pediatric Graft-Versus-Host Disease.
    Wadhwani SI; Nakayuenyongsuk W; Shinn L; Chase P; Kharbanda S; Bass D; Park KT
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e208-e209. PubMed ID: 27504814
    [No Abstract]   [Full Text] [Related]  

  • 6. Faecal calprotectin in term and preterm neonates.
    Kapel N; Campeotto F; Kalach N; Baldassare M; Butel MJ; Dupont C
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):542-7. PubMed ID: 20818270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.
    Montalto M; Gallo A; Ferrulli A; Visca D; Campobasso E; Cardone S; D'Onofrio F; Santoro L; Covino M; Mirijello A; Leggio L; Gasbarrini G; Addolorato G
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):76-80. PubMed ID: 21030869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants.
    Campeotto F; Baldassarre M; Butel MJ; Viallon V; Nganzali F; Soulaines P; Kalach N; Lapillonne A; Laforgia N; Moriette G; Dupont C; Kapel N
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):507-10. PubMed ID: 19322064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited value of fecal calprotectin in patients with liver cirrhosis.
    Burri E; Manz M; Rieder S; Beglinger C
    Scand J Gastroenterol; 2011 Dec; 46(12):1527-8. PubMed ID: 21905979
    [No Abstract]   [Full Text] [Related]  

  • 10. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation.
    Bjarnason I; Sherwood R
    J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):11-3. PubMed ID: 11479401
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective comparative study for new rapid bedside fecal calprotectin test with an established ELISA to assess intestinal inflammation.
    Shastri Y; Povse N; Stein J
    Clin Lab; 2009; 55(1-2):53-5. PubMed ID: 19350850
    [No Abstract]   [Full Text] [Related]  

  • 12. [Faecal calprotectin : a useful tool for the primary care physician ?].
    D'angelo F; Perrier A
    Rev Med Suisse; 2016 Oct; 12(535):1752-1756. PubMed ID: 28692215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin.
    Dolci A; Panteghini M
    Clin Chim Acta; 2012 Jan; 413(1-2):350-1. PubMed ID: 21982915
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
    Burri E; Manz M; Rothen C; Rossi L; Beglinger C; Lehmann FS
    Clin Chim Acta; 2013 Feb; 416():41-7. PubMed ID: 23178549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
    J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.
    Shastri YM; Bergis D; Povse N; Schäfer V; Shastri S; Weindel M; Ackermann H; Stein J
    Am J Med; 2008 Dec; 121(12):1099-106. PubMed ID: 19028207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin does not predict endoscopic remission in inflammatory bowel disease.
    Falvey JD; Gearry RB; Day AS
    Inflamm Bowel Dis; 2013 May; 19(6):E80-1. PubMed ID: 23619719
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of fecal calprotectin test in the work-up of IBS patients.
    Delgado-Aros S; Cremonini F
    Gastroenterology; 2003 Apr; 124(4):1164-5. PubMed ID: 12671919
    [No Abstract]   [Full Text] [Related]  

  • 20. Probiotics on fecal calprotectin of cystic fibrosis. Reply.
    Yousefi A; Shafieyoun A; Fallahi G; Rezaei N
    Turk J Pediatr; 2014; 56(3):333. PubMed ID: 25341616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.